CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells
Author:
Funder
NIH
NSF
National Science Foundation
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference245 articles.
1. Genome editing with engineered zinc finger nucleases;Urnov;Nat. Rev. Genet.,2010
2. TAL effectors: customizable proteins for DNA targeting;Bogdanove;Science,2011
3. Genome-Editing Technologies: Concept Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application;Khan;Mol. Ther. Nucleic Acids,2019
4. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation;Bhaya;Annu. Rev. Genet.,2011
5. RNA-guided genetic silencing systems in bacteria and archaea;Wiedenheft;Nature,2012
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications;Molecular Therapy - Nucleic Acids;2024-09
2. CRISPR-CAS9-MEDIATED EX VIVO GENE EDITING FOR INHERITED HEMATOLOGICAL DISORDERS: ADVANCEMENTS, CHALLENGES, AND CLINICAL POTENTIAL;International Journal of Pharmacy and Pharmaceutical Sciences;2024-09-01
3. Unleashing the potential of mRNA: Overcoming delivery challenges with nanoparticles;Bioengineering & Translational Medicine;2024-08-15
4. Tackling mosaicism in gene edited livestock;Frontiers in Animal Science;2024-06-03
5. Genome editing and its role in vaccine, diagnosis, and therapeutic advancement;International Journal of Biological Macromolecules;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3